Entering text into the input field will update the search result below

Mylan will be a no-show at Senate hearing

Nov. 22, 2016 3:48 AM ETViatris Inc. (VTRS) StockVTRSBy: Yoel Minkoff, SA News Editor6 Comments
  • Mylan (NASDAQ:MYL) won't be appearing at a November 30 Senate hearing about the EpiPen, stating its $465M settlement with the Justice Department is a "pending matter" and the DOJ will also not be attending.
  • At issue is whether Mylan underpaid government healthcare plans by classifying the Epipen as generic in the Medicaid Drug Rebate Program.

Recommended For You

About VTRS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VTRS--
Viatris Inc.